Figure 2. Decrease in RPL28 as biomarker for an efficient follow-up of anticancer therapy with Suberoyl-Bis-Hydroxamic Acid (SBHA). GATA6 is overexpressed in breast cancer cells. More remarkably MCF7 has higher expression of GATA6 which is slightly reduced after stable transfection of lamin A-RFP or treatment with SBHA for 12h. The reduction of RPL28 was significant after transfection of lamin A-RFP or treatment with SBHA.

From

Dynamism of Ribosomal Protein RPL28 as Biomarker for Monitoring Epigenetic-initiated-breast-cancer Therapy

Sara Houngu¨¨, Blanche Aguida, Callinice D. Capo-chichi

• Previous
• Figure 2 of 3  (Figures index)
• Next